CMA
61
-3
AXP
67
-2
FFIV
66
-4
VMC
53
-4
RL
69
-4
SEE
53
3
JNJ
41
3
KR
36
-6
COF
62
3
USB
50
-3
ABT
59
2
ADP
65
-3
NVDA
52
-5
GM
74
5
DFS
64
2
FOX
51
-6
MRO
50
4
TSCO
44
-4
BDX
56
10
NEM
40
3
CMA
61
-3
AXP
67
-2
FFIV
66
-4
VMC
53
-4
RL
69
-4
SEE
53
3
JNJ
41
3
KR
36
-6
COF
62
3
USB
50
-3
ABT
59
2
ADP
65
-3
NVDA
52
-5
GM
74
5
DFS
64
2
FOX
51
-6
MRO
50
4
TSCO
44
-4
BDX
56
10
NEM
40
3
Financhill
Back

Doubleline Opportunistic Credit Fund Vs. Avidity Biosciences Industry Stock Comparison

Sell
41

DBL
Doubleline Opportunistic Credit Fund

Last Price:
15.26
Seasonality Move:
1.61%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
41
Doubleline Opportunistic Credit Fund (DBL) is a Sell

Is Doubleline Opportunistic Credit Fund a Buy, Sell or Hold?

  • The current Doubleline Opportunistic Credit Fund [DBL] share price is $15.26. The Score for DBL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • DBL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DBL Stock Price Chart

What is Doubleline Opportunistic Credit Fund's stock price today?

  • The Doubleline Opportunistic Credit Fund share price today is $15.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBL is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

DBL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 38.25 Sell
Chaikin Money Flow: -35893 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.28 - 15.54) Sell
Bollinger Bands (100): (15.42 - 15.88) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

DBL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.45 Sell
20-day SMA: 15.37 Sell
50-day SMA: 15.65 Sell
200-day SMA: 15.38 Sell
8-day EMA: 15.39 Sell
20-day EMA: 15.44 Sell
50-day EMA: 15.54 Sell
200-day EMA: 15.4 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Doubleline Opportunistic Credit Fund Earnings Growth & DBL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.24 per share.

Doubleline Opportunistic Credit Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):